APA citiranje

Hammer, A., Waschbisch, A., Kuhbandner, K., Bayas, A., Lee, D., Duscha, A., . . . Linker, R. A. (2018). The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. Ann Clin Transl Neurol.

Citação norma Chicago

Hammer, Anna, Anne Waschbisch, Kristina Kuhbandner, Antonios Bayas, De‐Hyung Lee, Alexander Duscha, Aiden Haghikia, Ralf Gold, and Ralf A. Linker. "The NRF2 Pathway As Potential Biomarker for Dimethyl Fumarate Treatment in Multiple Sclerosis." Ann Clin Transl Neurol 2018.

MLA citiranje

Hammer, Anna, et al. "The NRF2 Pathway As Potential Biomarker for Dimethyl Fumarate Treatment in Multiple Sclerosis." Ann Clin Transl Neurol 2018.